WI
REGN icon

Westbourne Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Westbourne Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Hold
500
– – 0.13% 110
2026
Q1 		$386K Hold
500
– – 0.18% 102
2025
Q4 		$386K Hold
500
– – 0.18% 101
2025
Q3 		$326K Hold
500
– – 0.16% 96
2025
Q2 		$263K Hold
500
– – 0.14% 116
2025
Q1 		$317K Hold
500
– – 0.19% 104
2024
Q4 		$356K Buy
+500
New +$420K 0.21% 89

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Westbourne Investments's REGN Position: Q2 2026 in Review

Westbourne Investments held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 500 shares worth $312K. The position accounts for 0.13% of the portfolio, ranked #110.

Westbourne Investments first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $386K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Westbourne Investments held 500 shares of Regeneron Pharmaceuticals worth $312K as of Q2 2026.
  • Westbourne Investments left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.13% of Westbourne Investments's portfolio in Q2 2026, its #110 holding.
  • Westbourne Investments first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Westbourne Investments's Regeneron Pharmaceuticals position peaked at $386K in Q1 2026.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Westbourne Investments's 13F filing for Q2 2026, filed 11 Aug 2026.